MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial

    A. Benussi, V. Dell'Era, V. Cantoni, E. Bonetta, R. Grasso, R. Manenti, M. Cotelli, A. Padovani, B. Borroni (Brescia, Italy)

    Objective: The present study investigated whether a two-weeks' treatment with cerebellar anodal and spinal cathodal transcranial direct current stimulation (tDCS) could reduce symptoms in patients…
  • 2018 International Congress

    Changes detected in swallowing function in Friedreich ataxia over 12 months

    M. Keage, M. Delatycki, J. Dyer, L. Corben, A. Vogel (Carlton, Australia)

    Objective: To determine if changes in swallowing function are detectable over 12 months in Friedreich ataxia Background: Dysphagia (swallowing impairment) is present in 98% of…
  • 2018 International Congress

    FXN and ATXN2 methylation profile in Friedreich’s ataxia and spinocerebellar ataxia type 2

    E. Nuzhnyi, N. Abramycheva, T. Pogoda, S. Klyushnikov, M. Ershova, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)

    Objective: To compare methylation profiles in frataxin (FXN) and ataxin-2 (ATXN2) genes in patients with spinocerebellar ataxia type 2 (SCA2), Friedreich’s ataxia (FA) and a…
  • 2018 International Congress

    CASPR2 antibody mediated autoimmune encephalitis presenting with profound chorea

    S. Scotton, F. Manfredonia, P. Newman (Coventry, United Kingdom)

    Objective: Describing a rare case of CASPR2 medicated auto immune encephalitis presenting with profound chroea Background: This is a 69 year old retired engineer who…
  • 2018 International Congress

    Factors predicting patient satisfaction with botulinum toxin treatment in cervical dystonia patients who have been treated for a year

    V. Misra, C. Colosimo, T. Chung, D. Charles, S. Om, P. Maisonobe (London, United Kingdom)

    Objective: Investigate factors influencing satisfaction with botulinum toxin-A (BoNT-A) treatment in patients with cervical dystonia (CD) who have been treated for 1 year. Background: Little…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley